l

Home l UK Companies l Genomics Topics l Species with sequenced Genomes l Contact

l

GSK

Contact Details:
Address:Psychiatry Centre of Excellence for Drug Discovery
New Frontiers Science Park (North)
Harlow
Essex
Postcode:CM19 5AW
Country:UK

Loading...

Recent Publications by GSK:

Formulation considerations for developing toothpastes suitable for those at risk from erosive tooth wear.
The following viewpoint from PSI and EFSPI regarding the current level of...
GlaxoSmithKline Consumer Healthcare Weybridge, Surrey, UK. J Clin Dent. 2009;20(6):199-202.
Evaluation of different fluoridated dentifrice formulations using an in situ erosion remineralization model.
OBJECTIVE: The objective of these three clinical in situ studies was to...
GlaxoSmithKline Consumer Healthcare Weybridge, Surrey, UK. J Clin Dent. 2009;20(6):192-8.
Fluoride penetration from toothpastes into incipient enamel erosive lesions investigated using dynamic secondary ion mass spectrometry.
OBJECTIVE: The primary aim of this study was to assess the utility of...
GlaxoSmithKline Consumer Healthcare, Weybridge, UK. J Clin Dent. 2009;20(6):186-91.
Inhibition of enamel erosion and promotion of lesion rehardening by fluoride: a white light interferometry and microindentation study.
OBJECTIVE: The primary aim of the present in vitro studies was to...
GlaxoSmithKline Consumer Healthcare Weybridge, UK. J Clin Dent. 2009;20(6):178-85.
New in vitro and in situ evidence for a toothpaste formulated for those at risk from erosive tooth wear.
OBJECTIVE: The primary aim of the present in vitro studies was to...
GlaxoSmithKline Consumer Healthcare, Weybridge, UK. J Clin Dent. 2009;20(6):175-7.

GSK Patents:

US Patent No.Title
7400079 Ultrasonic probe
7388489 System and method for managing data on an RFID tag associated with a product
7367585 Inflating device for an air bag of a vehicle
4650574 Apparatus for the separation of solutions by pervaporation